| scholarly article | Q13442814 |
| P50 | author | Takayuki Asahara | Q92479059 |
| Cantas Alev | Q80222632 | ||
| P2093 | author name string | Toru Nakamura | |
| Masaaki Ii | |||
| Atsuhiko Kawamoto | |||
| Takato Ueno | |||
| Hironori Koga | |||
| Hideki Iwamoto | |||
| Takuji Torimura | |||
| Victor Tsutsumi | |||
| Mitsuhiko Abe | |||
| Atsutaka Masuda | |||
| Takahiko Sakaue | |||
| Fumitaka Wada | |||
| Yu Ikezono | |||
| Masako Naitou | |||
| Yasuko Imamura | |||
| P2860 | cites work | Prevention of liver fibrosis and liver reconstitution of DMN-treated rat liver by transplanted EPCs | Q83189221 |
| Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing | Q84594884 | ||
| Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model | Q84688343 | ||
| Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord | Q86405243 | ||
| Diverse functions of matrix metalloproteinases during fibrosis | Q26825368 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins | Q28202564 | ||
| Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy | Q28246439 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting | Q30320636 | ||
| Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist | Q33226787 | ||
| Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. | Q34558638 | ||
| Endothelial cell migration during angiogenesis | Q34613912 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. | Q35222121 | ||
| Bone marrow stem cells and liver disease. | Q35929494 | ||
| Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis | Q36861476 | ||
| Embryonic stem cells: hepatic differentiation and regenerative medicine for the treatment of liver disease | Q37066441 | ||
| Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis | Q37426714 | ||
| Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. | Q37768554 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Cilengitide inhibits metastatic bone colonization in a nude rat model | Q39513492 | ||
| Local transplantation of ex vivo expanded bone marrow-derived CD34-positive cells accelerates fracture healing | Q39559235 | ||
| Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration | Q40435527 | ||
| Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia | Q40608302 | ||
| Hepatic maturation in differentiating embryonic stem cells in vitro | Q40803055 | ||
| REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis | Q41120945 | ||
| Quality-control culture system restores diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure | Q42562746 | ||
| alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. | Q44739379 | ||
| Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis | Q46476283 | ||
| The effects of flap ischemia on normal and diabetic progenitor cell function | Q47666375 | ||
| Vascularized and functional human liver from an iPSC-derived organ bud transplant | Q48453997 | ||
| Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. | Q51867950 | ||
| CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. | Q53057906 | ||
| Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. | Q53248432 | ||
| Human peripheral blood CD34-positive cells enhance therapeutic regeneration of chronically injured liver in nude rats. | Q54364473 | ||
| Characterization and Clinical Application of Human CD34+Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor | Q61054157 | ||
| Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy | Q63285824 | ||
| Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia | Q73395331 | ||
| Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures | Q78570627 | ||
| Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model | Q80611344 | ||
| P304 | page(s) | 16025 | |
| P577 | publication date | 2016-04-27 | |
| P1433 | published in | Molecular Therapy. Methods & Clinical Development | Q27725341 |
| P1476 | title | Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis | |
| P478 | volume | 3 |
Search more.